Bhatt Nailesh
- SEC CIK
- 0001806525
No open-market purchases or sales filed in the past year.
Current role at each company
- PURR Hyperliquid Strategies IncDirectoras of Jul 6, 2026
- SONN Sonnet BioTherapeutics Holdings, Inc.Directoras of Dec 3, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bhatt Nailesh as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SONN Sonnet BioTherapeutics Holdings, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 18, 2023 (view filing)8:00 AM ET | May 17 | 1 day | Bhatt NaileshDirector | PPurchase | +25.0K | $0.232 | +$5.80K | +436.1%30.7K after |